Israeli-French breast cancer update Prevention, Detection and treatment
A multidisciplinary approach
King David hotel Jerusalem
From Wednesday 30th April to Friday 2nd May 2014.
Program on request: please contact – Sabine.email@example.com
On November 21 and 22, 2014 a selection of the most productive international
research groups will present their latest data on “prevention of breast cancers”. Indeed, we no longer can speak about breast cancer as a single disease but must recognise the many faces and biomolecular forms of breast cancer. Attention goes to the role of nutrition, practical chemoprevention, molecular differences, novel detection methods as well as vaccination to prevent the disease in the earliest stages. This milestone meeting will take place in the vibrant city of Genk/Hasselt, in the most eastern part of Belgium and a couple of miles from Maastricht.
More information: Sabine.firstname.lastname@example.org
Prof. Theodorus Agorastos, Greek gynecologist from the Aristotle University of Thessaloniki Hippokrateion General Hospital , has been appointed to Associate Editor of the European Journal of Cancer Prevention in the field of gynecological cancer prevention. His outstanding review work of many years contributed to the success of the Journal. We congratulate him with this demanding function.
A warm welcome to the website of ECP where all information can be found related to the organization, who we are, what we do and how you can participate in the fight against cancer through prevention.
Building a strong team fighting against cancer!
Within the European Community cancer causes more than 700,000 deaths per annum and a good proportion of these should be preventable. It has been estimated that 30 to 40 % of human cancers are caused by lifestyle and dietary factors. This number could be reduced by appropriate changes in lifestyle and diet. The early detection of cancer at various sites in the body has also been proved to save many lives. Not only does Europe offer a wide range in incidence of all of the most common cancers, but it also has a similarly wide range in dietary patterns, environmental exposures and social behavior. Europe offers an ideal ‘laboratory’ within which to test or to formulate hypotheses on the causation of human cancers.
Recent progresses in molecular biology together with the results of many epidemiological studies have greatly extended our research tools by identifying intermediate markers for cancer risk. These markers can identify individuals at increased risk for cancer and allow monitoring of preventive interventions or strategies. As more and more intermediate markers become available and new diagnostic tools emerge, primary prevention becomes a reality, with lots of power in the fight against cancer. Due to the availability of these new tools to the medical community and the growing body of preventive strategies, a shift from medical curative and palliative medicine into prevention has been noted. ECP, as a scientific organization with a worldwide network of co-workers and over 20 years experience, is ideally positioned to guide and support this process and ensure a solid transition from treatment to prevention in the most efficient fight against the disease. Various working groups conduct scientific research in the area of cancer prevention. For more information, please consult one of the ECP headquarters.
This website is constructed with the help of many researchers and members of ECP to guide you in the field of cancer prevention, who we are, what we do, and how you can join us for an important mission.
on behalf of ECP, Jaak Ph. Janssens ~ President
More info: email@example.com
The Working Group on Hormone Dependent Cancers devoted a substantial part of scientific research on new tissue acquisition tools to detect cancer but also to harvest high quality tissue for molecular profiling of cancer. Several papers have been published and novel technologies are picked-up by internationally active medical device companies. A great example of how scientific societies can collaborate with the industry and succeed.
A most recent collection on Cervical Cancer has been released on October 30, 2013 in the European Journal of Cancer Prevention.
Together with LWW, we found a compatibility issue to download the PDF of “Instructions for Authors” and “Copyright Transfer Form” . Due to these compatibility issues with the Form and the current version of Reader (Reader X), we recommend using Reader 9 when working with the Form. Reader 9 can be downloaded from http://get.adobe.com/reader/otherversions/.
Also the forms can be downloaded from this website:
- Instructions for Authors
- Copyright Transfer Form
The European Journal of Cancer Prevention has made substantial progress in the past few years. The number of downloads continues to increase as well as the submission rate and consequently also the Impact Factor that is now 2.974. Most importantly, the Journal contributed considerably to the global progress made in cancer prevention. In particular, much more attention has been given to the role of molecular biology in understanding the carcinogenetic process and to the consequences in implementing this knowledge. Clearly, a good choice and appreciated by our readers.
This progress is for a large part a result of a continuing commitment from reviewers and editors to the editorial process. A warm thanks to all who contributed !